Zevra Therapeutics (ZVRA) Interest Coverage Ratio (QoQ) (2014 - 2026)
Zevra Therapeutics (ZVRA) Interest Coverage Ratio (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,058.31% |
| Dec 31, 2025 | -257.44% |
| Sep 30, 2025 | 105.71% |
| Jun 30, 2025 | -3,744.67% |
| Mar 31, 2025 | 99.37% |
| Dec 31, 2024 | -3,394.92% |
| Sep 30, 2024 | 62.75% |
| Jun 30, 2024 | -241.30% |
| Mar 31, 2024 | -104.21% |
| Dec 31, 2023 | 287.08% |
| Sep 30, 2023 | -32.27% |
| Jun 30, 2023 | -228.22% |
| Mar 31, 2023 | 62.93% |
| Dec 31, 2022 | -530.71% |
| Sep 30, 2022 | 70.78% |
| Dec 31, 2021 | -313.22% |
| Sep 30, 2021 | -1,977.47% |
| Jun 30, 2021 | -91.94% |
| Mar 31, 2021 | 178.58% |
| Dec 31, 2020 | 2,597.48% |